BeStock  

Pulse Biosciences PLSE

US equityMarket cap rank #2349Medical Instruments & Supplies
$45.55 +$1.14 (+2.57%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $45.50 -0.11%
Open$44.00
Prev close$44.41
Day range$43.72 – $46.06
Volume466.9K
Market cap$3.35B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$395,000.00+359.3% YoY
Operating profit-$24.29M-19.3% YoY
Net profit-$23.05M-18.9% YoY
Diluted EPS-$0.32-10.3% YoY
Free cash flow-$15.42M-17.7% YoY
Operating cash flow-$15.27M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$86.0KSep '25$264.0KDec '25$401.0KMar '26$434.0KJun '26$395.0KSep '26

Net profit, last 8 quarters

$-19.4MDec '24$-16.8MMar '25$-19.2MJun '25$-19.4MSep '25$-17.4MDec '25$-18.6MMar '26$-24.7MJun '26$-23.1MSep '26

Diluted EPS by quarter

-0.31Dec '24-0.25Mar '25-0.28Jun '25-0.29Sep '25-0.26Dec '25-0.27Mar '26-0.36Jun '26-0.32Sep '26

Free cash flow by quarter

$-9.2MDec '24$-13.6MMar '25$-12.9MJun '25$-13.1MSep '25$-14.9MDec '25$-14.6MMar '26$-18.8MJun '26$-15.4MSep '26

Annual revenue

$0.0FY20$1.4MFY21$700.0KFY22$0.0FY23$0.0FY24$350.0KFY25

Profitability & balance sheet

Gross margin26.8%
Operating margin-5,821.1%
Net margin-5,603.9%
Return on equity-60.6%
Return on assets-54.0%
Return on invested capital-59.9%
Current ratio14.35
Liabilities / assets8.9%
Cash & investments$189.19M
Total debt$4.62M
Net cash (debt)$184.58M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $395,000.00 $434,000.00 $401,000.00 $350,000.00 $264,000.00
Total Operating Revenue $395,000.00 $434,000.00 $401,000.00 $350,000.00 $264,000.00
Cost of Revenue $191,000.00 $273,000.00 $370,000.00 $539,000.00 $260,000.00
Gross Profit $204,000.00 $161,000.00 $31,000.00 -$189,000.00 $4,000.00
Operating Expense $24.50M $25.43M $19.18M $76.75M $18.26M
Selling and Admin Expenses $7.65M $8.46M $6.59M $32.03M $7.33M
Research & Development $16.85M $16.98M $12.59M $44.72M $10.93M
Operating Profit -$24.29M -$25.27M -$19.15M -$76.94M -$18.25M
Net Non-Operating Interest Income (Expense) $1.21M $600,000.00 $593,000.00 $4.21M $825,000.00
Non-Operating Interest Income $1.21M $600,000.00 $593,000.00 $4.21M $825,000.00
Other Income (Expense) $36,000.00 $15,000.00 -$24,000.00 -$52,000.00 -$5,000.00
Other Non-Operating Income (Expenses) $36,000.00 $15,000.00 -$24,000.00 -$52,000.00 -$5,000.00
Pretax Profit -$23.05M -$24.66M -$18.58M -$72.78M -$17.43M
Net Profit -$23.05M -$24.66M -$18.58M -$72.78M -$17.43M
Profit from Continuing Operations -$23.05M -$24.66M -$18.58M -$72.78M -$17.43M
Net Income to Parent Company -$23.05M -$24.66M -$18.58M -$72.78M -$17.43M
Net Income to Common Stockholders -$23.05M -$24.66M -$18.58M -$72.78M -$17.43M
Basic EPS -$0.32 -$0.36 -$0.27 -$1.08 -$0.26
Diluted EPS -$0.32 -$0.36 -$0.27 -$1.08 -$0.26
-General & Admin Expense – $8.46M – – –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $201.58M $115.56M $81.62M $94.54M $94.54M
Total Current Assets $192.21M $105.70M $71.13M $83.42M $83.42M
Cash and Cash Equivalents & Short-Term Investments $189.19M $101.62M $68.32M $80.74M $80.74M
-Cash and Cash Equivalents $36.73M $101.62M $68.32M $80.74M $80.74M
-Short Term Investments $152.47M – – – –
Receivables $297,000.00 $122,000.00 $157,000.00 $274,000.00 $274,000.00
-Accounts Receivable $297,000.00 $122,000.00 $157,000.00 $274,000.00 $274,000.00
Inventory $232,000.00 $236,000.00 $206,000.00 $136,000.00 $136,000.00
Other Current Assets $2.49M $3.72M $2.45M $2.28M $2.28M
Total Non-Current Assets $9.38M $9.86M $10.49M $11.12M $11.12M
Net PPE $6.13M $6.45M $6.72M $7.06M $7.06M
-Gross PPE $6.13M $6.45M $6.72M $11.44M $11.44M
Goodwill and Other Intangible Assets $2.85M $3.01M $3.20M $3.37M $3.37M
-Goodwill $2.79M $2.79M $2.79M $2.79M $2.79M
-Other Intangible Assets $55,000.00 $222,000.00 $408,000.00 $575,000.00 $575,000.00
Other Non-Current Assets $398,000.00 $403,000.00 $575,000.00 $691,000.00 $691,000.00
Total Liabilities $18.01M $16.06M $15.32M $13.88M $13.88M
Total Current Liabilities $13.40M $10.98M $9.80M $7.92M $7.92M
Payables $3.02M $2.83M $2.76M $2.78M $2.78M
-Accounts Payable $3.02M $2.83M $2.76M $2.78M $2.78M
Current Accrued Expenses $4.24M $2.56M $2.12M $1.60M $1.60M
Short-Term Debt and Capital Lease Obligation $1.75M $1.69M $1.63M $1.57M $1.57M
-Current Capital Lease Obligation $1.75M $1.69M $1.63M $1.57M $1.57M
Total Non-Current Liabilities $4.62M $5.09M $5.53M $5.96M $5.96M
Long Term Debt and Capital Lease Obligation $4.62M $5.09M $5.53M $5.96M $5.96M
-Long Term Capital Lease Obligation $4.62M $5.09M $5.53M $5.96M $5.96M
Total Equity $183.57M $99.50M $66.30M $80.66M $80.66M
Stockholders' Equity $183.57M $99.50M $66.30M $80.66M $80.66M
Capital Stock $73,000.00 $71,000.00 $68,000.00 $68,000.00 $68,000.00
-Common Stock $73,000.00 $71,000.00 $68,000.00 $68,000.00 $68,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $713.15M $605.95M $548.09M $543.87M $543.87M
Retained Earnings -$529.57M -$506.52M -$481.86M -$463.28M -$463.28M
Gains/Losses Not Affecting Retained Earnings -$83,000.00 – – – –
-Accumulated Depreciation – – – -$4.37M -$4.37M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$15.27M -$18.71M -$14.60M -$54.12M -$14.76M
Net cash flow from continuing operations -$15.27M -$18.71M -$14.60M -$54.12M -$14.76M
Net Income from Continuing Operations -$23.05M -$24.66M -$18.58M -$72.78M -$17.43M
Depreciation & Depletion & Amortization $261,000.00 $254,000.00 $255,000.00 $1.07M $259,000.00
Other Non-Cash Items $553,000.00 $329,000.00 $370,000.00 $1.15M $306,000.00
Change in Working Capital $2.14M $392,000.00 $1.17M -$5.02M -$2.86M
-Change in Receivables -$121,000.00 $43,000.00 $55,000.00 -$274,000.00 -$259,000.00
-Change in Inventory $4,000.00 -$30,000.00 -$70,000.00 -$136,000.00 -$79,000.00
-Change in Prepaid Assets $346,000.00 -$433,000.00 -$129,000.00 -$912,000.00 -$360,000.00
-Change in Payables and Accrued Expense $2.31M $1.19M $1.68M -$2.32M -$1.81M
-Change in Other Current Assets $5,000.00 $4,000.00 $3,000.00 -$14,000.00 $14,000.00
-Change in Other Current Liabilities -$409,000.00 -$383,000.00 -$375,000.00 -$1.37M -$360,000.00
Net cash flow from investing -$152.49M -$90,000.00 -$33,000.00 -$335,000.00 -$105,000.00
Net Cash Flow from Continuing Investing Activities -$152.49M -$90,000.00 -$33,000.00 -$335,000.00 -$105,000.00
Net PPE Purchase and Sale -$142,000.00 -$90,000.00 -$33,000.00 -$315,000.00 -$105,000.00
Net Intangibles Purchase and Sale $0.00 – – -$20,000.00 $0.00
Financing Cash Flow $102.87M $52.10M $2.21M $17.15M $381,000.00
Net Cash Flow from Continuing Financing Activities $102.87M $52.10M $2.21M $17.15M $381,000.00
Net Common Stock Issuance $96.35M $45.93M $465,000.00 $0.00 $0.00
Proceeds from Stock Option Exercised $6.52M $6.12M $1.80M $17.15M $381,000.00
Ending Cash Balance $36.73M $101.62M $68.32M $80.74M $80.74M
Net Change in Cash -$64.90M $33.30M -$12.42M -$37.30M -$14.48M
Beginning Cash Balance $101.62M $68.32M $80.74M $118.04M $95.21M
Free Cash Flow -$15.42M -$18.80M -$14.63M -$54.46M -$14.86M
Net Other Financing Charges – – -$57,000.00 – –

Discussion

No comments yet — be the first to weigh in on PLSE.

Sign in to join the discussion.

Scroll to Top